Since the retinal region of patients with AMD may be exposed to blood circulating proteins and activation of the complement system could enhance the inflammatory process, we decided to investigate if patients with AMD with different CFH variants (Tyr402His) present differences in the plasma levels of the complement alternative pathway proteins CFH, C3, FB, FD, and FI. This evidence concerns the gene CFH and age-related macular degeneration.